Source:http://linkedlifedata.com/resource/pubmed/id/11274041
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
778-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading | |
pubmed:year |
2001
|
pubmed:articleTitle |
Chemiluminescent assay for serum thyroglobulin in the management of patients with thyroid carcinoma.
|
pubmed:affiliation |
The Immunoassay Laboratory, Department of Clinical Biochemistry, Barts and The London NHS Trust, 51-53 Bartholomew Close, London EC1A 7BE, United Kingdom. L.A.Perry@mds.qmw.ac.uk
|
pubmed:publicationType |
Journal Article,
Comparative Study
|